Canary Capital launches staked Injective ETF on Nasdaq under ticker INJC
Canary Capital has launched the Canary Staked INJ ETF on Nasdaq under the ticker INJC, offering exposure to Injective's native token while staking the underlying assets.

Canary Capital's Canary Staked INJ ETF has begun trading on Nasdaq under the ticker INJC, according to reports by The Block and BSC News following an announcement from Injective. The launch comes one day after the protocol announced that Nasdaq had approved the fund's listing.[2][3]
The fund provides exposure to Injective's native INJ token and participates in the network's proof-of-stake validation process, reflecting net staking rewards in its net asset value. At least 90% of the fund's INJ holdings will be staked, according to James Seyffart cited by Cointelegraph.[1][2]
A Form 8-A registration statement filed with the U.S. Securities and Exchange Commission registers common shares of beneficial interest for the Delaware-incorporated fund on The Nasdaq Stock Market LLC. Terminal data shared by Cointelegraph shows the actively managed ETF launched with an expense ratio of 1.100%, 600,000 shares outstanding, and $15 million in total assets.[1][3]
Key facts
- Canary Capital launched the Canary Staked INJ ETF on Nasdaq under the ticker INJC.
- The fund participates in Injective's proof-of-stake validation process and reflects net staking rewards in its net asset value.
- At least 90% of the ETF's INJ holdings are staked, according to James Seyffart.
- Injective announced the day prior to launch that Nasdaq had approved the listing.
- A Form 8-A filing with the SEC registers common shares of beneficial interest for the Delaware-incorporated Canary Staked INJ ETF on Nasdaq.
- Market data shows the ETF has an expense ratio of 1.100%, 600,000 shares outstanding, and $15 million in total assets.
Sources 路 3 sources
- CO
Cointelegraph@CointelegraphPost on X 路
馃敟 JUST IN: Canary's staked Injective ETF just went live on Nasdaq under $INJC, with at least 90% of its $INJ getting staked, per James Seyffart. https://t.co/UA787OhN9d
Open source - TB
The Block@TheBlockCoPost on X 路
THE BLOCK: Canary Capital has launched the Canary Staked INJ ETF on Nasdaq, offering investors exposure to Injective's native ethereum:0xe28b3b32b6c345a34ff64674606124dd5aceca30 token alongside potential staking rewards. The fund participates in Injective鈥檚 proof-of-stake validation process, with net staking rewards reflected in its net asset value. The ETF trades under the ticker $INJC .
Open source - BS
BSCN@BSCNewsPost on X 路
It happened... The first $INJ ETF is now live. As announced by @injective itself, Canary's $INJ staking ETF is now live on @Nasdaq with ticker $INJC. The protocol announced only yesterday that Nasdaq had approved the listing. Today is perhaps the biggest day in Injective's multi-year history.
Open source

